BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 24358183)

  • 1. Microbiota and metabolite profiling reveal specific alterations in bacterial community structure and environment in the cystic fibrosis airway during exacerbation.
    Twomey KB; Alston M; An SQ; O'Connell OJ; McCarthy Y; Swarbreck D; Febrer M; Dow JM; Plant BJ; Ryan RP
    PLoS One; 2013; 8(12):e82432. PubMed ID: 24358183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolic footprint of the airway bacterial community in cystic fibrosis.
    Narayanamurthy V; Sweetnam JM; Denner DR; Chen LW; Naureckas ET; Laxman B; White SR
    Microbiome; 2017 Jun; 5(1):67. PubMed ID: 28666467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbations.
    Fodor AA; Klem ER; Gilpin DF; Elborn JS; Boucher RC; Tunney MM; Wolfgang MC
    PLoS One; 2012; 7(9):e45001. PubMed ID: 23049765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fungal and Bacterial Diversity of Airway Microbiota in Adults with Cystic Fibrosis: Concordance Between Conventional Methods and Ultra-Deep Sequencing, and Their Practical use in the Clinical Laboratory.
    Botterel F; Angebault C; Cabaret O; Stressmann FA; Costa JM; Wallet F; Wallaert B; Bruce K; Delhaes L
    Mycopathologia; 2018 Feb; 183(1):171-183. PubMed ID: 28766039
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measures of Cystic Fibrosis Airway Microbiota during Periods of Clinical Stability.
    Caverly LJ; Lu J; Carmody LA; Kalikin LM; Shedden K; Opron K; Azar M; Cahalan S; Foster B; VanDevanter DR; Simon RH; LiPuma JJ
    Ann Am Thorac Soc; 2019 Dec; 16(12):1534-1542. PubMed ID: 31415187
    [No Abstract]   [Full Text] [Related]  

  • 6. Inflammation and airway microbiota during cystic fibrosis pulmonary exacerbations.
    Zemanick ET; Harris JK; Wagner BD; Robertson CE; Sagel SD; Stevens MJ; Accurso FJ; Laguna TA
    PLoS One; 2013; 8(4):e62917. PubMed ID: 23646159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.
    Hahn A; Sanyal A; Perez GF; Colberg-Poley AM; Campos J; Rose MC; Pérez-Losada M
    J Microbiol Methods; 2016 Nov; 130():95-99. PubMed ID: 27609714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culture enriched molecular profiling of the cystic fibrosis airway microbiome.
    Sibley CD; Grinwis ME; Field TR; Eshaghurshan CS; Faria MM; Dowd SE; Parkins MD; Rabin HR; Surette MG
    PLoS One; 2011; 6(7):e22702. PubMed ID: 21829484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Propidium Monoazide (PMA) Treatment on Mycobiome and Bacteriome Analysis of Cystic Fibrosis Airways during Exacerbation.
    Nguyen LD; Deschaght P; Merlin S; Loywick A; Audebert C; Van Daele S; Viscogliosi E; Vaneechoutte M; Delhaes L
    PLoS One; 2016; 11(12):e0168860. PubMed ID: 28030619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.
    Syed SA; Whelan FJ; Waddell B; Rabin HR; Parkins MD; Surette MG
    Ann Am Thorac Soc; 2016 Dec; 13(12):2132-2142. PubMed ID: 27925791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the Microbial Constituents of the Home Environment of Individuals with Cystic Fibrosis (CF) and Their Association with Lower Airways Infections.
    Heirali A; McKeon S; Purighalla S; Storey DG; Rossi L; Costilhes G; Drews SJ; Rabin HR; Surette MG; Parkins MD
    PLoS One; 2016; 11(2):e0148534. PubMed ID: 26859493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of airway microbiota in adults from a Brazilian cystic fibrosis center.
    Leite CCF; de Freitas FAD; de Cássia Firmida M; Leão RS; Albano RM; Marques EA
    Braz J Microbiol; 2020 Dec; 51(4):1747-1755. PubMed ID: 32944872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual Patterns of Complexity in Cystic Fibrosis Lung Microbiota, Including Predator Bacteria, over a 1-Year Period.
    de Dios Caballero J; Vida R; Cobo M; Máiz L; Suárez L; Galeano J; Baquero F; Cantón R; Del Campo R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28951476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyrosequencing Unveils Cystic Fibrosis Lung Microbiome Differences Associated with a Severe Lung Function Decline.
    Bacci G; Paganin P; Lopez L; Vanni C; Dalmastri C; Cantale C; Daddiego L; Perrotta G; Dolce D; Morelli P; Tuccio V; De Alessandri A; Fiscarelli EV; Taccetti G; Lucidi V; Bevivino A; Mengoni A
    PLoS One; 2016; 11(6):e0156807. PubMed ID: 27355625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic management.
    Delhaes L; Monchy S; Fréalle E; Hubans C; Salleron J; Leroy S; Prevotat A; Wallet F; Wallaert B; Dei-Cas E; Sime-Ngando T; Chabé M; Viscogliosi E
    PLoS One; 2012; 7(4):e36313. PubMed ID: 22558432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 16S rRNA-Based Microbiota Profiling Assists Conventional Culture Analysis of Airway Samples from Pediatric Cystic Fibrosis Patients.
    Kristensen M; de Koff EM; Chu ML; Groendijk S; Tramper-Stranders GA; de Winter-de Groot KM; Janssens HM; Tiddens HA; van Westreenen M; Sanders EAM; Arets BHGM; van der Ent CK; Prevaes SMPJ; Bogaert D
    Microbiol Spectr; 2023 Jun; 11(3):e0405722. PubMed ID: 37199622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chlamydia pneumoniae and Mycoplasma pneumoniae in children with cystic fibrosis: impact on bacterial respiratory microbiota diversity.
    Pittet LF; Bertelli C; Scherz V; Rochat I; Mardegan C; Brouillet R; Jaton K; Mornand A; Kaiser L; Posfay-Barbe K; Asner SA; Greub G
    Pathog Dis; 2021 Jan; 79(1):. PubMed ID: 33247928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of airway microbiota and inflammation in cystic fibrosis using multiple sampling methods.
    Zemanick ET; Wagner BD; Robertson CE; Stevens MJ; Szefler SJ; Accurso FJ; Sagel SD; Harris JK
    Ann Am Thorac Soc; 2015 Feb; 12(2):221-9. PubMed ID: 25474078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genus Prevotella in cystic fibrosis airways.
    Field TR; Sibley CD; Parkins MD; Rabin HR; Surette MG
    Anaerobe; 2010 Aug; 16(4):337-44. PubMed ID: 20412865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sputum DNA sequencing in cystic fibrosis: non-invasive access to the lung microbiome and to pathogen details.
    Feigelman R; Kahlert CR; Baty F; Rassouli F; Kleiner RL; Kohler P; Brutsche MH; von Mering C
    Microbiome; 2017 Feb; 5(1):20. PubMed ID: 28187782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.